Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 404

    Amgen gets FDA approval for BLINCYTO (blinatumomab) to treat Acute Lymphoblastic Leukemia

    Amgen gets FDA approval for BLINCYTO (blinatumomab) to treat Acute Lymphoblastic Leukemia

    Ruby Khatun Khatun16 July 2017 9:40 AM IST
    THOUSAND OAKS, Calif.: Amgen announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application...
    FDA Advisory Committee Recommends Approval of Mylan and Biocon

    FDA Advisory Committee Recommends Approval of Mylan and Biocon's Proposed Biosimilar Trastuzumab

    Ruby Khatun Khatun16 July 2017 9:10 AM IST
    HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India: Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration (FDA)...
    Anthem files lawsuit against Insys Therapeutics

    Anthem files lawsuit against Insys Therapeutics

    Ruby Khatun Khatun16 July 2017 9:03 AM IST
    Health insurer Anthem Inc filed a lawsuit against Insys Therapeutics Inc on Wednesday, alleging the drugmaker fraudulently obtained reimbursements for...
    Alkem Labs Plant clears USFDA inspection

    Alkem Labs Plant clears USFDA inspection

    Ruby Khatun Khatun15 July 2017 12:33 PM IST
    New Delhi: Alkem Laborato- Top 10 Most Influential Brands ries on Friday said the US health regulator has not issued any ‘observation’ post inspection...
    AstraZeneca slumps on report CEO is heading to Teva

    AstraZeneca slumps on report CEO is heading to Teva

    Ruby Khatun Khatun15 July 2017 9:48 AM IST
    LONDON: Shares in AstraZeneca fell more than 5 percent on Thursday after the company declined to deny a media report that Chief Executive Pascal...
    India Virtual Hospital launches an App to track patients recovery status.

    India Virtual Hospital launches an App to track patient's recovery status.

    Ruby Khatun Khatun15 July 2017 9:48 AM IST
    New Delhi: India Virtual Hospital, a tech enabled medical concierge service launched Patient Care App called "IVH patient care" which will help...
    Huawei Telecommunications contributes infrastructure to Government Hospital of Thoracic Medicine,Chennai

    Huawei Telecommunications contributes infrastructure to Government Hospital of Thoracic Medicine,Chennai

    Ruby Khatun Khatun15 July 2017 9:10 AM IST
    Chennai: Huawei Telecommunications India, a global leader in ICT solutions and a responsible corporate citizen, made a contribution of lifesaving...
    FDA shuts six medical stores in Haryana due to irregularities

    FDA shuts six medical stores in Haryana due to irregularities

    Ruby Khatun Khatun14 July 2017 9:51 AM IST
    Chandigarh: Under its special search operation, the Haryana Food and Drugs Administration (FDA) sealed six shops in different areas of the state for...
    Poly Medicure wins patent battle against B Braun melsungen in European market

    Poly Medicure wins patent battle against B Braun melsungen in European market

    Ruby Khatun Khatun14 July 2017 9:26 AM IST
    New Delhi: The German pharmaceutical and medical technology group B. Braun melsungen has lost a patent dispute with the Indian competitor Poly...
    Apollo Hospitals, Godrej HIT to launch first online Platelet Donor Community

    Apollo Hospitals, Godrej HIT to launch first online Platelet Donor Community

    Ruby Khatun Khatun14 July 2017 9:25 AM IST
    New Delhi: Apollo Hospitals on Tuesday announced its partnership with Godrej Hit to launch India’s first online Platelet Donor Community for dengue...
    Promoters divest 3.07 per cent stake in Ajanta Pharma

    Promoters divest 3.07 per cent stake in Ajanta Pharma

    Ruby Khatun Khatun14 July 2017 9:24 AM IST
    New Delhi: Drug firm Ajanta Pharma said its promoters have sold 27 lakh shares in the company representing about 3.07 per cent of its paid-up...
    Mallinckrodt settles US opioid drug probe for 35 million dollar

    Mallinckrodt settles US opioid drug probe for 35 million dollar

    Ruby Khatun Khatun14 July 2017 9:23 AM IST
    Mallinckrodt Plc, one of the largest manufacturers of the generic opioid painkiller oxycodone, will pay $35 million to resolve allegations that it...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Bayer appoints Bijoy Sagar as new Chief Information Technology & Digital Transformation Officer

    Bayer appoints Bijoy Sagar as new Chief Information Technology & Digital Transformation Officer

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok